GPC2
Basic information
Region (hg38): 7:100169606-100177381
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 55 | 60 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 55 | 5 | 0 |
Variants in GPC2
This is a list of pathogenic ClinVar variants found in the GPC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-100170234-C-T | not specified | Uncertain significance (Jun 28, 2023) | ||
7-100170271-T-A | not specified | Uncertain significance (May 30, 2023) | ||
7-100170298-T-G | not specified | Uncertain significance (Nov 10, 2022) | ||
7-100170303-G-A | not specified | Uncertain significance (Sep 13, 2023) | ||
7-100170310-C-G | not specified | Uncertain significance (Jun 11, 2024) | ||
7-100170310-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
7-100170321-C-T | not specified | Uncertain significance (Apr 28, 2022) | ||
7-100170385-G-A | not specified | Uncertain significance (Dec 10, 2024) | ||
7-100170405-C-T | not specified | Uncertain significance (Sep 26, 2024) | ||
7-100170420-A-C | not specified | Likely benign (Nov 18, 2022) | ||
7-100170469-C-T | not specified | Uncertain significance (Jan 20, 2025) | ||
7-100170478-C-T | not specified | Uncertain significance (Jul 10, 2024) | ||
7-100171291-G-C | not specified | Uncertain significance (Sep 13, 2023) | ||
7-100171315-T-G | not specified | Uncertain significance (Jul 13, 2021) | ||
7-100171320-G-A | not specified | Uncertain significance (Nov 14, 2024) | ||
7-100171344-C-T | not specified | Uncertain significance (Feb 28, 2025) | ||
7-100171408-G-C | not specified | Uncertain significance (Feb 02, 2022) | ||
7-100171419-A-G | not specified | Uncertain significance (Aug 17, 2021) | ||
7-100171425-G-A | not specified | Uncertain significance (Oct 30, 2023) | ||
7-100171543-C-T | not specified | Uncertain significance (May 01, 2024) | ||
7-100171569-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
7-100171581-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
7-100171596-A-C | not specified | Uncertain significance (Dec 11, 2023) | ||
7-100171617-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
7-100171627-G-C | not specified | Uncertain significance (Jun 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPC2 | protein_coding | protein_coding | ENST00000292377 | 10 | 7767 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0315 | 0.968 | 125733 | 0 | 14 | 125747 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.01 | 262 | 312 | 0.839 | 0.0000178 | 3565 |
Missense in Polyphen | 98 | 117.93 | 0.83102 | 1404 | ||
Synonymous | 0.873 | 120 | 133 | 0.904 | 0.00000707 | 1288 |
Loss of Function | 3.12 | 7 | 23.3 | 0.301 | 0.00000125 | 265 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000580 | 0.0000580 |
Ashkenazi Jewish | 0.000139 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000744 | 0.0000703 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cell surface proteoglycan that bears heparan sulfate. May fulfill a function related to the motile behaviors of developing neurons (By similarity). {ECO:0000250}.;
- Pathway
- Signaling by GPCR;Signal Transduction;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;Metabolism;Metabolism of vitamins and cofactors;Retinoid metabolism and transport;G alpha (i) signalling events;Visual phototransduction;GPCR downstream signalling;Glypican 2 network
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.87
- rvis_percentile_EVS
- 10.65
Haploinsufficiency Scores
- pHI
- 0.111
- hipred
- Y
- hipred_score
- 0.625
- ghis
- 0.620
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0988
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpc2
- Phenotype
- renal/urinary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- retinoid metabolic process;glycosaminoglycan biosynthetic process;glycosaminoglycan catabolic process;smoothened signaling pathway;regulation of signal transduction;neuron differentiation
- Cellular component
- extracellular space;endoplasmic reticulum;Golgi lumen;plasma membrane;lysosomal lumen;anchored component of plasma membrane;collagen-containing extracellular matrix
- Molecular function
- protein binding